Is atherosclerosis exclusively a postprandial phenomenon? (Q41455847)

30 September 2017

1 reference

title

Is atherosclerosis exclusively a postprandial phenomenon? (English)

1 reference

30 September 2017

1 reference

Mamo JC

1

1 reference

30 September 2017

Yu KC

2

1 reference

30 September 2017

Elsegood CL

3

1 reference

30 September 2017

Smith D

4

1 reference

30 September 2017

Vine D

5

1 reference

30 September 2017

Gennat HC

6

1 reference

30 September 2017

Voevodin M

7

1 reference

30 September 2017

Proctor SD

8

1 reference

30 September 2017

1 March 1997

1 reference

Clinical and Experimental Pharmacology and Physiology

30 September 2017

1 reference

30 September 2017

24

1 reference

30 September 2017

3-4

1 reference

30 September 2017

288-293

1 reference

Atherogenesis: a postprandial phenomenon

30 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB01822.X

Simultaneous measurement of apolipoprotein B turnover in very-low- and low-density lipoproteins in familial hypercholesterolaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB01822.X

Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB01822.X

Impact of hormone replacement therapy on postprandial lipoproteins and lipoprotein(a) in normolipidemic postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB01822.X

A receptor-mediated pathway for cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB01822.X

Hepatic uptake of chylomicron remnants in WHHL rabbits: a mechanism genetically distinct from the low density lipoprotein receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB01822.X

Chylomicron metabolism in normal, cholesterol-fed, and Watanabe heritable hyperlipidemic rabbits. Saturation of the sequestration step of the remnant clearance pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB01822.X

Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB01822.X

Chylomicron-remnant clearance in homozygote and heterozygote Watanabe-heritable-hyperlipidaemic rabbits is defective. Lack of evidence for an independent chylomicron-remnant receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB01822.X

Severe defect in clearing postprandial chylomicron remnants in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB01822.X

IDL, VLDL, chylomicrons and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB01822.X

Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB01822.X

Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.1997.TB01822.X

10.1111/J.1440-1681.1997.TB01822.X

21 January 2018

Identifiers

DOI

1 reference

30 September 2017

1 reference